A Randomized Non-Inferiority Study to Assess Immunogenicity, Safety, and Acceptability of Two vs. Three Doses of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Children, Adolescents and Young Adults Living with HIV in Eswatini
-
Filter
-
U
- All Projects
- Current
- Upcoming
- Past
- Multi-Country
-
Country +
- Angola
- Bahrain
- Belarus
- Botswana
- Brazil
- Bronx
- Burundi
- Cameroon
- Central Asia
- China
- Colombia
- Colombia and Peru
- Cote d'Ivoire
- Democratic Republic of the Congo
- Egypt
- El Salvador
- Eswatini
- Ethiopia
- Georgia
- Ghana
- Guatemala
- Haiti
- Harlem
- Honduras
- India
- Kazakhstan
- Kenya
- Kyrgyz Republic
- Kyrgyzstan
- Lesotho
- LesothoMalawi
- Liberia
- Malawi
- Mali
- Mauritania
- Mozambique
- Myanmar
- Namibia
- Nigeria
- Panama
- Peru
- Philippines
- Russia
- Rwanda
- Senegal
- Sierra Leone
- South Africa
- South Sudan
- Tajikistan
- Tanzania
- Thailand
- Uganda
- Uganda Refugees
- Ukraine
- United States
- Uzbekistan
- Vietnam
- Zambia
- Zimbabwe
